The Directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable September 1, 2009 to stockholders of record at the close of business on August 7, 2009.
Bristol-Myers Squibb Company is a global biopharmaceutical company whose mission is to extend and enhance human life.
A service of YellowBrix, Inc.
